Bosnia and Herzegovina vs Eswatini: Death rate from cardiomyopathy myocarditis endocarditis who ghe age
Bosnia and Herzegovina
12.03
in 2021
Eswatini
11.79
in 2021
Bosnia and Herzegovina rank
22nd
Eswatini rank
23rd
Death rate from cardiomyopathy myocarditis endocarditis who ghe age over time
- Bosnia and Herzegovina
- Eswatini
How they compare
Bosnia and Herzegovina currently reports 12.03 against 11.79 in Eswatini, a difference of 0.24.
The two have swapped places 4 times across 22 shared years of data; in 2000 it was Bosnia and Herzegovina ahead.
Bosnia and Herzegovina ranks 22nd and Eswatini ranks 23rd of 194 countries.
Across the 3 decades both report, Bosnia and Herzegovina averaged higher in 1 and Eswatini in 2.
Head to head by decade
| Decade | Bosnia and Herzegovina | Eswatini | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14 | 11.67 | 2.33 | Bosnia and Herzegovina |
| 2010s | 12.57 | 12.59 | 0.0266 | Eswatini |
| 2020s | 12.24 | 12.74 | 0.4986 | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from cardiomyopathy myocarditis endocarditis who ghe age, Bosnia and Herzegovina or Eswatini?
- Bosnia and Herzegovina, at 12.03 against 11.79 in Eswatini as of 2021.
- What is the difference in death rate from cardiomyopathy myocarditis endocarditis who ghe age between Bosnia and Herzegovina and Eswatini?
- 0.24, with Bosnia and Herzegovina ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Eswatini?
- 22 years are reported by both, from 2000 to 2021.
- How do Bosnia and Herzegovina and Eswatini rank globally for death rate from cardiomyopathy myocarditis endocarditis who ghe age?
- Bosnia and Herzegovina ranks 22nd and Eswatini ranks 23rd of 194 countries.
- Where does this data come from?
- Our World in Data, published as Death rate from cardiomyopathy myocarditis endocarditis who ghe age standardized. Statizoid refreshes it automatically from the source and publishes the full history for both places.